MIVIX
Price
$29.91
Change
-$0.03 (-0.10%)
Updated
Jul 13 closing price
Net Assets
317.96M
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

MIVIX vs VSTSX

MIVIX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
MIVIX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIVIX is a Hold and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. MIVIX (318M). VSTSX pays higher dividends than MIVIX: VSTSX (1.07) vs MIVIX (0.47). MIVIX was incepted earlier than VSTSX: MIVIX (6 years) vs VSTSX (10 years). MIVIX (0.81) is less costly to investors than VSTSX (0.01). MIVIX is a more actively managed with annual turnover of: 21.00 vs. VSTSX (3.00). MIVIX has a lower initial minimum investment than VSTSX: MIVIX (250000) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. MIVIX (2.16). VSTSX return over 5 years is better than : 66.56 vs. MIVIX (10.90).
MIVIXVSTSXMIVIX / VSTSX
Total Expense Ratio0.810.018,100%
Annual Report Gross Expense Ratio0.810.018,100%
Fund Existence6 years10 years-
Gain YTD7.58211.20568%
Front LoadN/AN/A-
Min. Initial Investment25000050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets318M2.3T0%
Annual Yield % from dividends0.471.0744%
Returns for 1 year2.1621.4810%
Returns for 3 years14.6367.0622%
Returns for 5 years10.9066.5616%
Returns for 10 yearsN/A239.53-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I